These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: Comparability of children's sedentary time estimates derived from wrist worn GENEActiv and hip worn ActiGraph accelerometer thresholds.
    Author: Boddy LM, Noonan RJ, Kim Y, Rowlands AV, Welk GJ, Knowles ZR, Fairclough SJ.
    Journal: J Sci Med Sport; 2018 Oct; 21(10):1045-1049. PubMed ID: 29650338.
    Abstract:
    OBJECTIVES: To examine the comparability of children's free-living sedentary time (ST) derived from raw acceleration thresholds for wrist mounted GENEActiv accelerometer data, with ST estimated using the waist mounted ActiGraph 100count·min-1 threshold. DESIGN: Secondary data analysis. METHOD: 108 10-11-year-old children (n=43 boys) from Liverpool, UK wore one ActiGraph GT3X+ and one GENEActiv accelerometer on their right hip and left wrist, respectively for seven days. Signal vector magnitude (SVM; mg) was calculated using the ENMO approach for GENEActiv data. ST was estimated from hip-worn ActiGraph data, applying the widely used 100count·min-1 threshold. ROC analysis using 10-fold hold-out cross-validation was conducted to establish a wrist-worn GENEActiv threshold comparable to the hip ActiGraph 100count·min-1 threshold. GENEActiv data were also classified using three empirical wrist thresholds and equivalence testing was completed. RESULTS: Analysis indicated that a GENEActiv SVM value of 51mg demonstrated fair to moderate agreement (Kappa: 0.32-0.41) with the 100count·min-1 threshold. However, the generated and empirical thresholds for GENEActiv devices were not significantly equivalent to ActiGraph 100count·min-1. GENEActiv data classified using the 35.6mg threshold intended for ActiGraph devices generated significantly equivalent ST estimates as the ActiGraph 100count·min-1. CONCLUSIONS: The newly generated and empirical GENEActiv wrist thresholds do not provide equivalent estimates of ST to the ActiGraph 100count·min-1 approach. More investigation is required to assess the validity of applying ActiGraph cutpoints to GENEActiv data. Future studies are needed to examine the backward compatibility of ST data and to produce a robust method of classifying SVM-derived ST.
    [Abstract] [Full Text] [Related] [New Search]